Skip to main content

Advertisement

SpringerLink
Log in

Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus–Infected Burn Wound in Mice

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is considered a common colonizer of burn wound and accounts for high morbidity and mortality all across the globe. Systemic antibiotic therapy which is generally prescribed for these patients has a number of limitations. These include high drug dose, toxicity, and chances of development of drug resistance. However, local delivery of drug not only addresses these limitations but also provides better efficacy at the site of infection. In the present study, hydrogel preparations were developed for the topical delivery of moxifloxacin for the treatment of S. aureus–infected burn wound. Moxifloxacin was characterized by UV, FTIR, DSC, hot-stage microscopy, NMR, and HPLC and loaded into conventional and Boswellia-containing novel gels. Gels were characterized by visual examination, pH, UV spectroscopy, and release assays. In vivo studies showed that both gels were effective in eradicating the bacteria completely from the wound site when treatment was started during the early stage of infection. On the contrary, delayed treatment of planktonic and biofilm cells with novel gel showed better efficacy as compared with conventional gel in S. aureus–infected burn wound. Histopathological analysis also showed better skin healing efficacy of novel gel than conventional gel. Our results show that moxifloxacin can be efficiently used topically in the management of burn wound infections along with other antibacterial agents. Since biofilm-mediated infections are on the rise especially in chronic bacterial disease, therefore, a preparation containing antibiofilm agent-like Boswellia as one of the excipients would be more meaningful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–31.

    Article  CAS  Google Scholar 

  2. Vashist A, Vashist A, Gupta YK, Ahmad S. Recent advances in hydrogel based drug delivery systems for the human body. J Mater Chem B. 2014;2(2):147–66.

    Article  CAS  Google Scholar 

  3. Penesyan A, Gillings M, Paulsen I. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules. 2015;20(4):5286–98.

    Article  CAS  Google Scholar 

  4. Alhede M, Kragh KN, Qvortrup K, Allesen-Holm M, van Gennip M, Christensen LD, et al. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One. 2011;6(11):e27943.

    Article  CAS  Google Scholar 

  5. Macia MD, Rojo-Molinero E, Oliver A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect. 2014;20(10):981–90.

    Article  CAS  Google Scholar 

  6. Pond SM, Tozer TN. First-pass elimination basic concepts and clinical consequences. Clin Pharmacokinet. 1984;9(1):1–25.

    Article  CAS  Google Scholar 

  7. Miller D. Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophthalmol (Auckland, NZ). 2008;2(1):77.

    Article  CAS  Google Scholar 

  8. Chilet-Rosell E, Ruiz-Cantero MT, Pardo MA. Gender analysis of moxifloxacin clinical trials. J Women's Health. 2014;23(1):77–104.

    Article  Google Scholar 

  9. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–34.

    Article  Google Scholar 

  10. Park HY, Kim CR, Huh IS, Jung MY, Seo EY, Park JH, et al. Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis. Ann Dermatol. 2013;25(4):410–6.

    Article  Google Scholar 

  11. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.

    Article  CAS  Google Scholar 

  12. Tarai B, Das P, Kumar D. Recurrent challenges for clinicians: emergence of methicillin-resistant Staphylococcus aureus, vancomycin resistance, and current treatment options. J Lab Phys. 2013;5(2):71–8.

    Google Scholar 

  13. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect. 2009;10(5):389–97.

    Article  Google Scholar 

  14. Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. BMC Microbiol. 2011;11(1):54.

    Article  CAS  Google Scholar 

  15. Finnegan S, Percival SL. EDTA: an antimicrobial and antibiofilm agent for use in wound care. Adv Wound Care. 2015;4(7):415–21.

    Article  Google Scholar 

  16. Agnihotri N, Gupta V, Joshi RM. Aerobic bacterial isolate from burn wound infections and their antibiograms - a five - year study. Burns. 2004;30:241–3.

    Article  CAS  Google Scholar 

  17. Donati L, Scammazo F, Gervasoni M, Magliano A, Stankow B, et al. Infection and antibiotic therapy in 4000 burned patients in Milani Italy between 1976 and 1988. Burns. 1993;19(4):345–8.

    Article  CAS  Google Scholar 

  18. Komolafe OO, James J, Kalongolera L, Makoka M. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235–8.

    Article  CAS  Google Scholar 

  19. Alebachew T, Yismaw G, Derabe A, Sisay Z. Staphylococcus aureus burn wound infection among patients attending Yekatit 12 hospital burn unit, Addis Ababa, Ethiopia. Ethiop J Health Sci. 2012;22:3.

    Google Scholar 

  20. Garau J, Bouza E, Chastre J, Gudiol F, Harbarth S. Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect. 2009;15(2):125–36.

    Article  CAS  Google Scholar 

  21. McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2009;29(3):263–80.

    Article  CAS  Google Scholar 

  22. Jacobsen F, Fisahn C, Sorkin M, Thiele I, Hirsch T, Stricker I, et al. Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55(5):2325–34.

    Article  CAS  Google Scholar 

  23. Dai T, Tanaka M, Huang YY, Hamblin MR. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti-Infect Ther. 2011;9(7):857–79.

    Article  CAS  Google Scholar 

  24. Ali Khan Z, Jamil S, Akhtar A, Mustehsan Bashir M, Yar M. Chitosan based hybrid materials used for wound healing applications-a short review. Int J Polym Mater Polym Biomater. 2019:1–8.

  25. Dholakia M, Thakkar V, Patel N, Gandhi T. Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel. J Pharm Bioallied Sci. 2012;4(Suppl 1):S42–5.

    Article  CAS  Google Scholar 

  26. Sheikh AA. Development and characterization of novel in situ gel of moxifloxacin hydrochloride. Asian J Pharm. 2017;11:03.

    Google Scholar 

  27. El-Sharif AA, Hussain MH. Chitosan–EDTA new combination is a promising candidate for treatment of bacterial and fungal infections. Curr Microbiol. 2011;62(3):739–45.

    Article  CAS  Google Scholar 

  28. Sadhasivam S, Palanivel S, Ghosh S. Synergistic antimicrobial activity of Boswellia serrata Roxb. ex Colebr.(Burseraceae) essential oil with various azoles against pathogens associated with skin, scalp and nail infections. Lett Appl Microbiol. 2016;63(6):495–501.

    Article  CAS  Google Scholar 

  29. Deepak SN, Hari BV. Optimization, development and evaluation of microemulsion for the release of combination of guaifenesin and phenylephrine. J Appl Pharm Sci. 2013;3(9):48.

    Google Scholar 

  30. Ashraf MA, Khan AM, Sarfraz M, Ahmad M. Effectiveness of silica based sol-gel microencapsulation method for odorants and flavors leading to sustainable environment. Front Chem. 2015;3:42.

    Article  Google Scholar 

  31. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28(5):359–70.

    Article  CAS  Google Scholar 

  32. Figueiredo KA, Neves JK, Silva JA, Freitas RM, Carvalho AL. Phenobarbital loaded microemulsion: development, kinetic release and quality control. Braz J Pharm Sci. 2016;52(2):251–64.

    Article  Google Scholar 

  33. Chhibber S, Gondil VS, Singla L, Kumar M, Chhibber T, Sharma G, et al. Effective topical delivery of H-AgNPs for eradication of Klebsiella pneumoniae–induced burn wound infection. AAPS PharmSciTech. 2019;20(5):169.

    Article  Google Scholar 

  34. Gondil VS, Chhibber S. Exploring potential of phage therapy for tuberculosis using model organism. Biomed Biotechnol Res J. 2018;2(1):9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India

    Tanya Chhibber & V. R. Sinha

  2. Department of Microbiology, Basic Medical Sciences, Panjab University, Chandigarh, India

    Vijay Singh Gondil

Authors
  1. Tanya Chhibber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijay Singh Gondil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. R. Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. R. Sinha.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chhibber, T., Gondil, V.S. & Sinha, V.R. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus–Infected Burn Wound in Mice. AAPS PharmSciTech 21, 43 (2020). https://doi.org/10.1208/s12249-019-1537-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-019-1537-2

KEY WORDS

Search

Navigation